These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4413595

  • 1. Gout and hyperlipidaemia.
    Gibson T, Grahame R.
    Ann Rheum Dis; 1974 Jul; 33(4):298-303. PubMed ID: 4413595
    [No Abstract] [Full Text] [Related]

  • 2. Gout and hyperlipidaemia.
    Gibson T, Grahame R.
    Adv Exp Med Biol; 1974 Jul; 41():499-508. PubMed ID: 4832574
    [No Abstract] [Full Text] [Related]

  • 3. Hyperlipoproteinaemia in gout.
    Bluestone R, Lewis B, Mervart I.
    Ann Rheum Dis; 1971 Mar; 30(2):134-7. PubMed ID: 5569433
    [No Abstract] [Full Text] [Related]

  • 4. Mechanism and treatment of hypertriglyceridaemia in gout.
    Gibson T, Kilbourn K, Horner I, Simmonds HA.
    Ann Rheum Dis; 1979 Feb; 38(1):31-5. PubMed ID: 434944
    [Abstract] [Full Text] [Related]

  • 5. Study of the effect of hypouricaemic therapy on serum lipid levels in gout patients.
    Darlington LG, Scott JT.
    Adv Exp Med Biol; 1986 Feb; 195 Pt A():341-4. PubMed ID: 3728165
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
    Günther R, Knapp E.
    Wien Klin Wochenschr; 1970 Jan 30; 82(5):78-82. PubMed ID: 5513199
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of decrease in hyperuricemia levels on joint, kidney and other symptoms in patients with gout].
    Kawenoki-Minc E.
    Ter Arkh; 1987 Jan 30; 59(4):25-8. PubMed ID: 3589999
    [No Abstract] [Full Text] [Related]

  • 10. Observations concerning the incidence of disturbance of lipid and carbohydrate metabolism in gout.
    Frank O.
    Adv Exp Med Biol; 1974 Jan 30; 41():495-8. PubMed ID: 4832573
    [No Abstract] [Full Text] [Related]

  • 11. Medical management of gout.
    Gutman AB.
    Postgrad Med; 1972 May 30; 51(6):61-6. PubMed ID: 5028822
    [No Abstract] [Full Text] [Related]

  • 12. Familial hyperuricaemia and hypertriglyceridaemia.
    Bennett RM, Chait A, Lewis B.
    Ann Rheum Dis; 1973 Nov 30; 32(6):497-500. PubMed ID: 4760474
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperlipidemia in primary gout.
    Yü TF, Dorph DJ, Smith H.
    Semin Arthritis Rheum; 1978 May 30; 7(4):233-44. PubMed ID: 347582
    [No Abstract] [Full Text] [Related]

  • 16. Gout and hyperlipidaemia. Effect of overweight on the levels of circulating lipids.
    Rondier J, Truffert J, le Gô A, Cayla J, Hila A, de Gennes JL, Delbarre F.
    Ann Clin Res; 1977 Aug 30; 9(4):239-45. PubMed ID: 616208
    [Abstract] [Full Text] [Related]

  • 17. [The effect of spironolactone and thiabutazide on serum-uric acid and lipid levels in patients with gout and in healthy persons].
    Mertz DP.
    Dtsch Med Wochenschr; 1973 Jan 05; 98(1):11-5. PubMed ID: 4684940
    [No Abstract] [Full Text] [Related]

  • 18. Hyperlipidaemia in gout.
    Nishida Y, Akaoka I, Nishizawa T, Yoshimura T.
    Clin Chim Acta; 1975 Jul 09; 62(1):103-6. PubMed ID: 1149265
    [Abstract] [Full Text] [Related]

  • 19. [Allopurinol in the treatment of gout].
    Sabah D.
    Rev Med Chil; 1970 Jul 09; 98(9):622-7. PubMed ID: 5509800
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.